SUNITCAP-SUNITINIB MALATE CAPSULES 50MG
Sold by RADHAKRUSHNA MEDICALS · Distributor, Exporter, Wholesaler · Yavatmal, Maharashtra, India
Sold by RADHAKRUSHNA MEDICALS · Distributor, Exporter, Wholesaler · Yavatmal, Maharashtra, India
US
PH
XG
GB
BD
+46 others
Importers · Distributors · Wholesalers
RADHAKRUSHNA MEDICALS is a Distributor, Exporter, Wholesaler based in Yavatmal Maharashtra India.
Distributor, Exporter, Wholesaler · Yavatmal, Maharashtra, India
"Radhakrushna Medicals: Your Destination for Critical Care & Speciality Medicines. Surgical Suture Vaccines "
Registered address: Yavatmal, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.
US
PH
XG
GB
BD
+46 others
Description SUNITCAP 50 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that blocks receptors involved in tumor growth, angiogenesis (blood vessel formation), and cancer cell survival, thereby slowing cancer progression.Uses Sunitinib is used in adults for the treatment of:1. Advanced / metastatic Renal Cell Carcinoma (RCC)2. Gastrointestinal Stromal Tumor (GIST) – After failure or intolerance to imatinib3. Pancreatic Neuroendocrine Tumors (pNETs) – Unresectable or metastatic, well-differentiated rx_imgPrescription Required
Description provided by RADHAKRUSHNA MEDICALS.
| Dosage Form | Capsule |
|---|---|
| Strength | 50mg |
| Route of Administration | Oral |
| Indications | Advanced/Metastatic Renal Cell Carcinoma, GIST post-imatinib failure, Unresectable/Metastatic Pancreatic Neuroendocrine Tumors |
| Packaging Unit | Bottle |
| Storage Conditions | Store at room temperature, protect from moisture |
| Prescription Status | Prescription required |
| Treatment Cycle | 6 weeks (4 weeks on drug, 2 weeks off) or continuous dosing |
| Side Effects | Fatigue, diarrhea, nausea, hypertension, cardiac toxicity, thyroid dysfunction |
| Monitoring Requirements | Blood pressure, liver function, thyroid function, cardiac status |
| Category | Pharmaceuticals > Oncology > Targeted Cancer Therapies > Tyrosine Kinase Inhibitors |
|---|---|
| Primary application | Wholesale, distribution, and international sourcing |
| Brand | Not specified |
| Product type | Product |
| Lead time | On request |
|---|---|
| Packaging | As per buyer requirement |
| Storage condition | As recommended by supplier |
| Origin | India |
| Form | As listed by supplier |
| Minimum order | 1 Bottle |
|---|---|
| Lead time | On request |
| Payment terms | As per negotiated commercial agreement. |
Common questions B2B buyers ask before sourcing SUNITCAP-SUNITINIB MALATE CAPSULES 50MG. Answers compiled from verified sellers' commercial terms and platform data.
Post one RFQ and get quotes from all verified sellers within 48 hours. No commitment, no spam.
Post a RFQ